CNS Pharmaceuticals (NASDAQ: CNSP) pivots to neurology and oncology amid going concern risk

Better Home & Finance sued its founder and former CEO Vishal Garg, alleging he led a “scorched-earth campaign” to regain control. The dispute follows claims during his tenure that he called employees “monkeys” and “dumb dolphins.” Better Home says Garg was reinstalled as CEO in 2022 after a 2021 mass layoff. The lender has processed over $110B in loans.

Bill Ackman’s Pershing Square disclosed a new position in Netflix (NFLX), lifting the stock about 4% to $78.80 in Tuesday trading. The move followed a prior 2022 Netflix stake that ended in a loss. Disney (DIS) and Warner Bros. Discovery (WBD) rose less than 1%, suggesting a Netflix-specific catalyst. Netflix trades at 28.83x trailing P/E and is down 16% YTD.

LEO Pharma agreed to acquire worldwide rights to Tanabe Pharma’s dersimelagon for up to $435m. The late-stage oral drug completed Phase III, with an FDA NDA filed June 2026. Thermo Fisher and KYAN Technologies will collaborate on precision oncology using patient-derived tumoroids. Biogen’s felzartamab won China NMPA approval for multiple myeloma. Expedition Therapeutics raised $115m Series B for EXPD-101 COPD Phase II.

ExxonMobil said it awarded about $1.1 billion in pre-investment contracts for upstream equipment for the Rovuma LNG Phase 1 project in Mozambique’s Cabo Delgado. The awards, made for Area 4 partners including ENH, CNOOC, Eni, Korea Gas and ADNOC, cover subsea production systems, valves and offshore line pipe to support a final investment decision. OneSubsea UK/AS received the largest contract.

The US military, according to Reuters, awarded Raytheon (an RTX unit) a seven-year $22.9 billion contract to expand Tomahawk missile output from about 60 missiles per year to over 1,000. The deal follows a February framework agreement and is aimed at replenishing depleted US precision-guided weapons inventories.

Cummins Inc. (CMI) said its Power Generation unit was selected to supply battery energy storage systems for a major U.S. data center project, which it expects to be its largest BESS deployment. The 5MWh lithium iron phosphate system is designed to manage AI-driven power fluctuations, reduce load oscillations, and support bridge-to-grid use with diesel or natural gas. CMI shares were $623.90 on NYSE.